Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Predicting Age by Profiling Circulating Plasma Proteins

By LabMedica International staff writers
Posted on 16 Dec 2019
It has been shown to be possible to calculate the age of an individual by measuring levels of various proteins circulating in the blood plasma.

Aging is a predominant risk factor for several chronic diseases that limit longevity, and mechanisms that regulate aging have become increasingly recognized as potential therapeutic targets.

To evaluate biochemical factors linked to aging, investigators at Stanford University (Palo Alto, CA, USA) measured 2,925 plasma proteins from 4,263 young adults to nonagenarians (18–95 years old). More...
Some of the samples came from the LonGenity study, which had accumulated blood samples from a cohort of exceptionally long-lived Ashkenazi Jews.

The investigators measured the levels of roughly 3,000 proteins in plasma samples from each individual. Results revealed 1,379 proteins with levels that varied significantly with participants' age. By employing a new bioinformatics approach that uncovered marked non-linear alterations in the human plasma proteome with age, the investigators were able to define a reduced set of 373 proteins that was sufficient to predict participants' ages with considerable accuracy.

The investigators also discovered waves of changes in the distribution of plasma proteins in the fourth, seventh, and eighth decades of life (roughly at ages 34, 60, and 78), which reflected distinct biological pathways and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits.

"We have known for a long time that measuring certain proteins in the blood can give you information about a person's health status - lipoproteins for cardiovascular health, for example," said senior author Dr. Tony Wyss-Coray, professor of neurology and neurological sciences, at Stanford University. "But it has not been appreciated that so many different proteins' levels - roughly a third of all the ones we looked at - change markedly with advancing age."

The study was published in the December 5, 2019, online edition of the journal Nature Medicine.

Related Links:
Stanford University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.